Members of Verseon's Scientific Advisory Board

Steven Chu, PhD is the former Secretary of Energy from 2009 to 2013. He was awarded the Nobel Prize in Physics in 1997 for his work on laser cooling of atoms at Bell Labs. He has also served on the faculty of University of California, Berkeley and as director of the Lawrence Berkeley National Laboratory from 2004 to 2009. He is currently Professor of Physics and Molecular and Cellular Physiology at Stanford University.

Robert Karr, MD is the former Senior Vice President of R&D Strategy at Pfizer. Prior to its merger with Pfizer, he served as Vice President, R&D for Warner-Lambert Company. He currently serves on the Board of Directors of Idera Pharmaceuticals. He also served as a faculty member at both the University of Iowa College and Washington University School of Medicine.

John Leonard, MD is the former Senior Vice President, Chief Scientific Officer of AbbVie Inc. Prior to Abbvie, he was the Senior Vice President, Pharmaceutical R&D for Abbott, responsible for guiding Abbot’s research and development efforts including HIV antiviral drugs and other therapies. He completed his internship and residency at Stanford University School of Medicine followed by a post-doctoral fellowship in molecular virology at the National Institute of Allergy and Infectious Diseases.

Michael Berelowitz, MD is the former Senior Vice President of Clinical Development at Pfizer. Prior to his time at Pfizer, he was Professor of Medicine and served as Head, Division of Endocrinology and Metabolism at Stony Brook University School of Medicine. He is currently Adjunct Clinical Professor of Medicine, Division of Endocrinology at Mount Sinai School of Medicine.

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods

 

Drug Programs

Three different therapeutic areas, all with unmet (or poorly met) medical needs